CN102091237A - Product for nano magnetic-anion far-infrared functional dress therapy - Google Patents
Product for nano magnetic-anion far-infrared functional dress therapy Download PDFInfo
- Publication number
- CN102091237A CN102091237A CN2010102760646A CN201010276064A CN102091237A CN 102091237 A CN102091237 A CN 102091237A CN 2010102760646 A CN2010102760646 A CN 2010102760646A CN 201010276064 A CN201010276064 A CN 201010276064A CN 102091237 A CN102091237 A CN 102091237A
- Authority
- CN
- China
- Prior art keywords
- radix
- respectively account
- chinese medicine
- rhizoma
- nano
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002560 therapeutic procedure Methods 0.000 title claims abstract description 17
- 239000003814 drug Substances 0.000 claims abstract description 69
- 230000000694 effects Effects 0.000 claims abstract description 33
- 150000001450 anions Chemical class 0.000 claims abstract description 23
- 239000004744 fabric Substances 0.000 claims abstract description 20
- 239000000835 fiber Substances 0.000 claims abstract description 19
- 230000036541 health Effects 0.000 claims abstract description 9
- 238000011282 treatment Methods 0.000 claims description 24
- 239000007788 liquid Substances 0.000 claims description 15
- 238000002360 preparation method Methods 0.000 claims description 15
- 238000009987 spinning Methods 0.000 claims description 13
- 229910052613 tourmaline Inorganic materials 0.000 claims description 13
- 229940070527 tourmaline Drugs 0.000 claims description 13
- 239000011032 tourmaline Substances 0.000 claims description 13
- 208000002193 Pain Diseases 0.000 claims description 12
- 210000004185 liver Anatomy 0.000 claims description 12
- 239000000843 powder Substances 0.000 claims description 12
- 210000000582 semen Anatomy 0.000 claims description 12
- 229920000742 Cotton Polymers 0.000 claims description 11
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 claims description 10
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims description 8
- 241000717739 Boswellia sacra Species 0.000 claims description 7
- 239000004863 Frankincense Substances 0.000 claims description 7
- 229910004298 SiO 2 Inorganic materials 0.000 claims description 7
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 7
- 241000628997 Flos Species 0.000 claims description 6
- 210000001113 umbilicus Anatomy 0.000 claims description 6
- 241001057584 Myrrha Species 0.000 claims description 5
- 229910010413 TiO 2 Inorganic materials 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- 230000001684 chronic effect Effects 0.000 claims description 5
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N iron oxide Inorganic materials [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 claims description 5
- 239000011858 nanopowder Substances 0.000 claims description 5
- 206010003445 Ascites Diseases 0.000 claims description 4
- 241000903946 Clematidis Species 0.000 claims description 4
- 241000218176 Corydalis Species 0.000 claims description 4
- 208000005171 Dysmenorrhea Diseases 0.000 claims description 4
- 206010013935 Dysmenorrhoea Diseases 0.000 claims description 4
- 241000283898 Ovis Species 0.000 claims description 4
- 150000002825 nitriles Chemical class 0.000 claims description 4
- 241000237903 Hirudo Species 0.000 claims description 3
- 229920000297 Rayon Polymers 0.000 claims description 3
- 208000034189 Sclerosis Diseases 0.000 claims description 3
- 239000004408 titanium dioxide Substances 0.000 claims description 3
- 241000282472 Canis lupus familiaris Species 0.000 claims description 2
- 206010008685 Chondritis Diseases 0.000 claims description 2
- 239000003242 anti bacterial agent Substances 0.000 claims description 2
- 229910021538 borax Inorganic materials 0.000 claims description 2
- 150000002500 ions Chemical class 0.000 claims description 2
- 230000002175 menstrual effect Effects 0.000 claims description 2
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 2
- 238000012856 packing Methods 0.000 claims description 2
- 239000004328 sodium tetraborate Substances 0.000 claims description 2
- 235000010339 sodium tetraborate Nutrition 0.000 claims description 2
- 241000972155 Moschus Species 0.000 claims 1
- 230000017531 blood circulation Effects 0.000 abstract description 5
- 210000002421 cell wall Anatomy 0.000 abstract description 4
- 230000001965 increasing effect Effects 0.000 abstract description 4
- 238000010438 heat treatment Methods 0.000 abstract description 3
- 230000001105 regulatory effect Effects 0.000 abstract description 3
- 238000009826 distribution Methods 0.000 abstract description 2
- 239000005557 antagonist Substances 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 18
- 210000004369 blood Anatomy 0.000 description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- 201000010099 disease Diseases 0.000 description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 11
- 238000000034 method Methods 0.000 description 11
- 208000012886 Vertigo Diseases 0.000 description 10
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 9
- 230000036772 blood pressure Effects 0.000 description 9
- 208000024891 symptom Diseases 0.000 description 8
- 229940079593 drug Drugs 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 6
- 230000001225 therapeutic effect Effects 0.000 description 6
- 229910052500 inorganic mineral Inorganic materials 0.000 description 5
- 239000000395 magnesium oxide Substances 0.000 description 5
- 235000010755 mineral Nutrition 0.000 description 5
- 239000011707 mineral Substances 0.000 description 5
- 239000011573 trace mineral Substances 0.000 description 5
- 235000013619 trace mineral Nutrition 0.000 description 5
- 206010020772 Hypertension Diseases 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 239000011777 magnesium Substances 0.000 description 4
- 239000011148 porous material Substances 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 230000005855 radiation Effects 0.000 description 4
- 230000008929 regeneration Effects 0.000 description 4
- 238000011069 regeneration method Methods 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 239000011701 zinc Substances 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000011651 chromium Substances 0.000 description 3
- IJKVHSBPTUYDLN-UHFFFAOYSA-N dihydroxy(oxo)silane Chemical compound O[Si](O)=O IJKVHSBPTUYDLN-UHFFFAOYSA-N 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 230000000857 drug effect Effects 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 230000005714 functional activity Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 210000003141 lower extremity Anatomy 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- 229910044991 metal oxide Inorganic materials 0.000 description 3
- 150000004706 metal oxides Chemical class 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 239000011669 selenium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 229910052725 zinc Inorganic materials 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 244000153234 Hibiscus abelmoschus Species 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 208000012287 Prolapse Diseases 0.000 description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- WGLPBDUCMAPZCE-UHFFFAOYSA-N Trioxochromium Chemical compound O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 230000008485 antagonism Effects 0.000 description 2
- 239000002220 antihypertensive agent Substances 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000000919 ceramic Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000035487 diastolic blood pressure Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 239000003651 drinking water Substances 0.000 description 2
- 235000020188 drinking water Nutrition 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- AMWRITDGCCNYAT-UHFFFAOYSA-L hydroxy(oxo)manganese;manganese Chemical compound [Mn].O[Mn]=O.O[Mn]=O AMWRITDGCCNYAT-UHFFFAOYSA-L 0.000 description 2
- 230000001631 hypertensive effect Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 229910052744 lithium Inorganic materials 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 210000004417 patella Anatomy 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 229910052711 selenium Inorganic materials 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 229910052712 strontium Inorganic materials 0.000 description 2
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 208000001889 Acid-Base Imbalance Diseases 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N Alumina Chemical compound [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 241000255789 Bombyx mori Species 0.000 description 1
- 206010006811 Bursitis Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 235000014653 Carica parviflora Nutrition 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 241000243321 Cnidaria Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000190633 Cordyceps Species 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108010061435 Enalapril Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000201295 Euphrasia Species 0.000 description 1
- 229910001111 Fine metal Inorganic materials 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000007177 Left Ventricular Hypertrophy Diseases 0.000 description 1
- 208000029549 Muscle injury Diseases 0.000 description 1
- 206010050031 Muscle strain Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 241000237636 Pheretima Species 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 201000002661 Spondylitis Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 208000021945 Tendon injury Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000011358 absorbing material Substances 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 229940127088 antihypertensive drug Drugs 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 210000001217 buttock Anatomy 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 description 1
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 1
- 239000000292 calcium oxide Substances 0.000 description 1
- 229940025250 camphora Drugs 0.000 description 1
- 239000010238 camphora Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000003727 cerebral blood flow Effects 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 229910000423 chromium oxide Inorganic materials 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000011443 conventional therapy Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- GBXSMTUPTTWBMN-XIRDDKMYSA-N enalapril Chemical compound C([C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(O)=O)CC1=CC=CC=C1 GBXSMTUPTTWBMN-XIRDDKMYSA-N 0.000 description 1
- 229960000873 enalapril Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 238000010035 extrusion spinning Methods 0.000 description 1
- 210000003195 fascia Anatomy 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- YOBAEOGBNPPUQV-UHFFFAOYSA-N iron;trihydrate Chemical compound O.O.O.[Fe].[Fe] YOBAEOGBNPPUQV-UHFFFAOYSA-N 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 206010025005 lumbar spinal stenosis Diseases 0.000 description 1
- 210000004705 lumbosacral region Anatomy 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- 238000002653 magnetic therapy Methods 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- -1 polypropylene Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- CHWRSCGUEQEHOH-UHFFFAOYSA-N potassium oxide Chemical compound [O-2].[K+].[K+] CHWRSCGUEQEHOH-UHFFFAOYSA-N 0.000 description 1
- 229910001950 potassium oxide Inorganic materials 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 150000004760 silicates Chemical class 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 208000005198 spinal stenosis Diseases 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 208000013460 sweaty Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000035488 systolic blood pressure Effects 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 229910052720 vanadium Inorganic materials 0.000 description 1
- GPPXJZIENCGNKB-UHFFFAOYSA-N vanadium Chemical compound [V]#[V] GPPXJZIENCGNKB-UHFFFAOYSA-N 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
- 229910000859 α-Fe Inorganic materials 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention relates to a product for a nano magnetic-anion far-infrared functional dress therapy, belonging to the technical field for producing healthy fiber fabrics, clothing, shoe pads, chest and waist belts, navel treating belts and the like. Nano Chinese medicine processed by a Chinese medicine superfine processing device is added; due to the large specific surface area of the medicine, the distribution of medicine elements in a human body is increased, thereby improving the biological utilization ratio and the effect of the medicine; the cell wall of the nano Chinese medicine is damaged, and the medicine effect is fully exposed so that the Chinese medicine has an amazing effect. The product is small in medicine dosage, small in range and good in treating effect; besides, the product has a magnetic treating function and can go deep into 3-5 mm under the skin; and the blood circulation is speeded up by automatically heating, various microelements are continuously dissolved out, the element balance in an antagonist is regulated, and anions are continuously produced to improve the health of the human body.
Description
Technical field:
Nano-magnetic anion far infrared effect hat and clothes therapy articles for use of the present invention are to belong to health fiber textile fabric clothing shoe pad breast belt Umbilical therapeutic bag to manufacture technical field.
Background technology:
The hat and clothes therapy is that have existed since ancient times, be to utilize jewelrys such as wearing the clothes of people attached the names of pre-determined candidates, footgear, shoe pad, jewelry, breast belt, Umbilical therapeutic bag, with medicine be sewn on wherein wear on one's body, osmotic absorption by skin pore, sweat pore, blood capillary is circulated to whole body with active drug molecule, trace element effective ingredient through blood, performance, treatment, replenish, the multiple effect of adjusting, antagonism trace element, be a kind of Perfected process of external therapy of Chinese herb.The Tang Dynasty Sun Simiao is write in " prescriptions worth thousand gold ": it is strong to control head term, can not turn round and look to look, and the steaming Semen sojae atricolor is a pipeful of, makes its variable color, includes in and makees medicated pillow in the cloth bag.Ancients also make medicated cap to Flos Chrysanthemi, Herba Menthae, Camphora etc., clear away heart-fire in order to drive away summer heat, and medicines such as plug pain relieving that Herba Asari, Radix Aconiti Kusnezoffii etc. are dispeled the wind, loose are made shoe pad and put shoe lining into, perhaps all add this type of medicine in making military footwear in the shoe pad upper of a shoe.Fight to trudging, marching and do not think tired, put the merit that medicated cap has brain-strengthening, keeps fit into Moschus, adding Chen Aiye with Flos Chrysanthemi makes knee cap and can control knee joint wind pain, Testa Fagopyri Esculenti, Testa sojae atricolor, Semen Cassiae, Flos Chrysanthemi can cause always with the work pillow and make eye bright, but make the pillow liver heat removing and eyesight improving with Flos Chrysanthemi, Semen phaseoli radiati, Spica Prunellae, fall summer-heat and reduce phlegm and internal heat with Bombyx mori L., residual Folium Camelliae sinensis work pillow, put midsole with Radix Glycyrrhizae, the Radix Angelicae Dahuricae and keep away sweaty foot, anti-damaging by worms.The magnetic therapy clothes and trousers of curing the disease, shoes and hats, necklace, bangle, wrist-watch etc. in recent years with Magnetitum, magnetic field.
The hat and clothes therapy is the method for a kind of ancient treatment disease in external treatment with Chinese medicine field, the present invention adopts and makes the part serve the present, make foreign things serve china, with the Chinese medicine nanotechnology of latest modern technological with the makeup of Chinese medicine element superfine put processing Chinese medicine such as Chinese medicine Placenta Hominis, Cordyceps, dried Pheretima can be all by skin absorbs, nanoscale minerals as Chinese medicine material absorbance for oral administration also increases substantially, can reach more than 98% as preparations such as calcium, zinc, ferrum, nanometer Chinese medicine element, because its big specific surface area has increased the surface area that is exposed in the medium, has promoted the release dissolubility of medicine.Because the particle diameter of medicine element molecule reduces, and has increased the distribution in vivo of medicine element, has improved bioavailability, the drug effect effect of medicine element widely.Say that generally the Chinese medicine element is before nanotechnology treatments not, cell wall is complete, its effective ingredient also has only very little a part of penetration cell wall stripping, and the utilization that is absorbed by the body, take the complete breaking cellular wall of their cell wall of Chinese medicine element of nanotechnology, make more Chinese medicine element effective ingredient discharge the utilization that is absorbed by the body, thereby make the Chinese medicine element receive beyond thought fancy effect.
Maifanitum contains composition and mainly contains titanium dioxide TiO
2, silicon dioxide SiO
2, aluminium sesquioxide Al
2O
3, iron sesquioxide Fe
2O
3, multiple macro micro elements such as ferrous oxide, ferrum oxide, manganese oxide, calcium oxide, potassium oxide, manganese, zinc, nickel, cobalt, silicon, copper, selenium, germanium, fluorine, iodine, chromium, magnesium, sodium, lithium, vanadium, strontium to the human body beneficial, they are again maximum metal-oxide and carbide such as magnesium oxide MgO, chromium oxide and the chromic oxide Cr of effect in the common far infrared radiation material simultaneously
2O
3, MnO
2, ZrO
2, BaO etc.The dissolving out capability of Maifanitum is good especially, be soaked in water and just be easy to stripping calcium Ca, magnesium Mg, potassium K, sodium Na, strontium Sr, selenium Se, zinc Zn, iodine I, element and mineral such as metasilicic acid, Maifanitum be used for drinking-water can make water near and reach the mineral water standard, long-term drink has the anti-fatigue anoxia-tolerance effect, and enhancing human body immunity power function, improve health anti-infective ability, diuresis is arranged, be good for the stomach, the function that protects the liver, to hypertension, diseases such as sclerosis of blood vessels all produce effect, bathe the treatment dermatosis with the impregnated washing of Maifanitum positive effect is arranged, Maifanitum can adsorbed water in to the deleterious cadmium Cd of animals and plants, hydrargyrum Hg, plumbous Pb, odorous gas such as heavy metal elements such as arsenic As and hydrogen sulfide, can adsorb simultaneously microorganisms such as escherichia coli, virus and other organic substances, get rid of animal toxicity in vivo material, has strengthening the spleen and stomach, protect the liver dirty, resisting fatigue, regulate metabolism, strengthen biological effects such as blood circulation and immunity.The water that soaked through Maifanitum can make desalt, mineralising, activation, as the mineral water that drinks cool Gan Kou, makes the people obtain important nutrient source, so Maifanitum is described as " cell cleaning agent ".Water is Source of life, the tissue 65% of human body is made up of water, people's blood 80% is water, people's eyeball 99% is a water, in a single day human body loses 20% is moisture, vital movement just will terminate, fine water is that human body is grand, the important channel that trace element is supplied with, it is a human body conveying mineral matter, fat, nutritional labeling such as oxygen and hormone, play heat radiation simultaneously, dilution, multiple effects such as drainage we can say that all physiological activities of human body all be unable to do without the participation of water, and the human body various diseases is cardiovascular and cerebrovascular disease especially, the pollution of cancer etc. and daily drinking water, lack beneficial trace elements, the acid base imbalance of water quality has much relations.
(MgO, Al in the Maifanitum
2O
3, TiO
2, SiO
2, Cr
2O
3, Fe
2O
3, MnO
2) etc. also be the material of common far infrared radiation character in the main component, also be to use maximum metal-oxides, also belong to the electromagnetic ferrite of absorption, basic iron powder, super-fine metal powder etc. and belong to magnetizing mediums type electromagnetic wave, absorbing material belongs to one-object-many-purposes, life sciences confirms, human body is a far infrared wire spoke source, it also is a far-infrared absorption source, the far infrared wavelength of its emission is 5～25um, the optimal absorption wave band is 4～16um, and the main component that constitutes human body cell is hydrone and macromolecular compound.Occupy 65% moisture in the general health, 80% moisture in the blood, as insufficiency of vital energy and blood, hydrone in the blood just is combined into inertia water (four hydrogen molecules and an oxygen molecule), can not produce mass exchange with human tissue cell by cell membrane, far-infrared engergy produces resonance effect with hydrone, makes it become independently hydrone (two hydrogen molecules and an oxygen molecule), improves the oxygen content of health, increase the vigor of cell, make people's spirit more vigorous, brains is more flexible, and then disease resistance enhancemen, slow down aging, resonance makes subcutaneous tissue deep layer position, and heating up automatically and generate heat in promptly subcutaneous 3～5mm place, produces the heat effect hydrone and be activated, be in upper state, quicken the synthetic of needed by human body enzyme, blood vessel dilating promotes blood of human body circulation and metabolism, thereby enhancing body's immunological function, strengthen the regeneration capacity of human-body biological cell tissue, quicken microcirculation, quicken the supply that oxygen divides, get rid of harmful substance in the body, play a series of medical care effect.
In the anion-generating material most widely used be a kind of be aluminum, sodium, ferrum, the magnesium of feature, the silicate of lithium circulus with the boracic, the main component of its main component and Maifanitum is similar, is Al
2O
3, TiO
2, SiO
2, Fe
2O
3, MgO, ZnO etc., tourmaline is inorganic porous material and the coral fossil that the metal-oxide of silicate and aluminum, ferrum constitutes, bottom sediment, aethiops vegetabilises etc. are main silicates, porous mass has permanent spontaneous electrode, promptly be to be subjected to small variation also can make surrounding air generation ionization, produce anion.Maifanitum, tourmaline composite Nano micropowder are added to cotton, fiber crops, silk, brocade, wash, in the fiber spinning solution such as polypropylene, make the various functional fiber fabrics of anion far infrared through operations such as extrusion spinnings and produce hat and clothes therapy articles for use such as the dual-use footwear of our necessary medicative fabrics, socks, pad, knee cap bandage, obi, shoulder pad, scarf.
Perhaps our the nano-far-infrared anion powder that can be directly produce by the refreshing High Seience Technology Co., Ltd. of Beijing Jie Er
900, anion far infrared health size
700, anion far-infrared finishing agent
Add medicative effective Chinese medicinal formulae in 888 productions such as grade, Maifanitum, tourmaline nano powder body are used for the fabric spinning liquid such as footwear, socks, belt of hat and clothes therapy, produce our needed various effect fabric materials.By contacting with skin pore tight the nanometer Chinese medicine element molecule infiltration in the fabric to skin histology, the regeneration capacity of blood circulation promoting and cell promotes the well-being of mankind its hat and clothes therapy articles for use better.
In order to protect from infection effectively and the strong disinfecting deodorization, in the iatric fiber preparation, add nanometer silver system (AT) titanium oxide inorganic antibacterial purpose, promote inflammation to disappear, ailing rapid recovery:
The present invention is further described below in conjunction with examples of implementation:
Embodiment one:
1, Chinese medicine preparation 1
(1) form: Hirudo, Fructus Evodiae, each 50g of Radix Platycodonis respectively account for 4.9%; Ramulus Uncariae Cum Uncis, each 120g of Semen Cassiae respectively account for 11.8%; Rhizoma Chuanxiong, Flos Chrysanthemi, Folium Mori, Spica Prunellae, each 100g of Semen Sinapis Albae respectively account for 9.8%; Rhizoma Gastrodiae 80g accounts for 7.8%; Borneolum Syntheticum 30g accounts for 2.9%; Cortex Cinnamomi 20g accounts for 2%.
(2) usage: said medicine is dried and is ground to the powder, be sewn into the thick 3～4mm of 3.5 * 3.5cm (each medicated cushion needs medicamental pulverata 10g approximately, can do 100 medicated cushion by above-mentioned dose preparation) with double gauze and be seated in sole Yongquan acupoint, every day 1 time, changed 1 time in 10 days, 20 days is a course of treatment; Or direct medicamental pulverata after the Chinese medicine nanotechnology is added in the spinning liquid gets final product.
(3) matched group is with the antihypertensive drugs of conventional therapy amount.
(4) observational technique and index:
This group treatment target 300 examples, the object of observation 60 examples, wherein male 88 examples, woman's 175 examples, 25～73 years old age, the course of disease 20～152a, 58 years old mean age, all all carry out complete physical examination before and after the patient, comprise electrocardiogram, blood, urine, stool three big routine examinations, comprehensive collection arrangements such as blood glucose, glucose in urine, transaminase, high blood viscosity, hyperlipidemia, T-CHOL, triglyceride and medical history, sign, symptom, tongue fur, pulse, the auxilliary cardiac determination of heart enzyme.
(5) treatment standard: formulate standard by WHD in 1999
Produce effects: more than the diastolic pressure decline 1.33kpa, reach normal range, symptom disappears substantially;
Effectively: diastolic pressure is the preceding decline 1.33kpa～2.53kpa of treatment, but does not reach normal range, more than the decline 4kpa, feels good before systolic pressure is treated;
Invalid: as not reach above standard person's symptom no change.
(6) therapeutic outcome: (seeing attached list)
Subordinate list
(7) model case:
The king * *, man, 53 years old, cadre, on May 3rd, 2008 went to a doctor, and hypertension history was arranged 13 years, and the state of an illness increases the weight of closely over the past half year, and is dizzy, tinnitus, vexed xerostomia, the few tongue of red tongue, deep pulse is counted accurately, blood pressure 23/14kpa, heart rate 92 times/minute, electrocardiogram shows: left ventricular hypertrophy strain, each 2 of oral antihypertensive compound tablet Pan Dingsheng, 1 time/day, oral first quarter moon, blood pressure lowering is not obvious, but it is sleepy that feel is fainted, and body is tired weak, advises drug withdrawal depressor.Use the blood pressure lowering medicated cushion, symptom obviously alleviates after 5 days, measuring blood pressure 20/12.5kpa after 1 course of treatment, uses two courses of treatment after patient's blood pressure keep stable, spirit and QI cleaning, it is normal that long-time later on use antihypertensive medicinal pillow is kept blood pressure, no longer enalapril meleate.
(8) discuss:
Hypertensive method of treatment and medicine are a lot of at present, but with nanometer Chinese medicine element fabric shoe pad method, the domestic blood pressure lowering medicated cushion that is not reported of treatment primary disease is taken as the leading factor with theory of channels and collaterals based on theory of Chinese medical science, with trace element balance medical science, negative and positive are regulated, and acid-base balance is an aim, the collection Drug therapy, channel-dradging, adjusting, additional, antagonism element balance, health body-building, life lengthening are one.
(9) pharmacology analysis:
The Hirudo power general trend of events warm in nature hero in the side, removing blood stasis, the eliminating stagnation of being open to the custom is apt to into spring, and sensible 12 warps draw for all medicines, Ramulus Uncariae Cum Uncis, Rhizoma Gastrodiae heat clearing away suppressing the hyperactive liver, the arresting convulsion that relieves dizziness, high fever, infantile convulsions, epilepsy, etc. is apt to control nose heave dizzy; The Semen Cassiae liver heat removing and eyesight improving, beneficial smart the kidney invigorating; Spica Prunellae suppressing the hyperactive liver sun, Disperse hepatic depression.Last four Chinese medicine has the effect of blood pressure lowering, calmness and cholesterol reducing.The Rhizoma Chuanxiong promoting flow of QI and blood, dissipating depression of QI is transferred liver, the up head, the descending sea of blood, it has the reduction blood viscosity modern pharmacological research, reduces cerebral vascular resistance, the effect of cerebral blood flow increasing amount; Fructus Evodiae, the dry spleen of Cortex Cinnamomi kidney tonifying should be led blood vessels, guiding fire to origin; Borneolum Syntheticum perfume (or spice) is scurried benefaction, the stagnated fire of loosing, logical all keys, quench refreshment, hypertensive tranquilizing; Semen Sinapis Albae, Radix Platycodonis promoting the circulation of QI eliminating stagnation, the outer expectorant of flesh side film of dispelling.All in a word medicines share maximizes favourable factors and minimizes unfavourable ones, play altogether and reach heresy and dispel the wind, the heat clearing away suppressing the hyperactive liver, conducting fire back to its origin, regulating YIN and YANG, the calm the nerves merit of blood pressure lowering, can play effects such as blood fat reducing, the turbid descending, calmness, diuresis, arteriosclerosis, slow down aging again, and the fragrance of medicine own scurries, ward off dirty dispel turbid, can eliminate foot's fetid sweat, play the merit of disease-relieving and physique enhancing.
2, Chinese medicine preparation 2: dysmenorrhea is loose or bag is controlled dysmenorrhea
Cortex Cinnamomi, Rhizoma Zingiberis Preparatum, Oletum Trogopterori, Pollen Tyjphae, each 60g of Rhizoma Corydalis respectively account for 10.6%; Radix Angelicae Sinensis, Rhizoma Chuanxiong, Radix Paeoniae Rubra, Semen Persicae, each 50g of Rhizoma Cyperi respectively account for 8.8%; Succinum end 15g accounts for 2.7%;
Or, respectively accounting for 25% with Cortex Cinnamomi, Rhizoma Corydalis, Herba Asari, each 50g of Fructus Foeniculi, deposited umbilicus is controlled and is stimulated the menstrual flow.3, Chinese medicine preparation 3: applying Chinese medicine to the umbilicus bag treatment intractable cirrhotic ascites
Radix Phytolaccae 100g accounts for 61.3%; Moschus 3g accounts for 1.8%; Resina Ferulae, each 30g of Borax respectively account for 18.4%, grind the deck of packing into into powder, apply umbilicus treating the liver sclerosis ascites.
4, Chinese medicine preparation 4: the Chinese medicine waistline is controlled chronic lambago and skelalgia
(1) form: Radix Aconiti, Radix Aconiti Kusnezoffii, Semen Strychni (processed), Semen Sinapis Albae, Herba Asari, Olibanum, Myrrha, Cortex Cinnamomi, each 50g of Borneolum Syntheticum respectively account for 1.3%; Canis familiaris L. spring, Rhizoma Drynariae, the Cortex Eucommiae, each 100g of Radix Angelicae Sinensis respectively account for 2.7%; Scholar unit, Radix Cyathulae, Radix Clematidis, Radix Angelicae Pubescentis, Periostracum Cicadae, Radix Gentianae Macrophyllae, Rhizoma Atractylodis, Cortex Phellodendri, Rhizoma Polygonati Odorati, each 200g of the Radix Paeoniae Alba respectively account for 5.3%; Radix Salviae Miltiorrhizae, Semen Coicis, each 300g of Magnetitum respectively account for 8%.
(2) method:
1. above-mentioned Chinese medicine is chosen the broken nano-ceramic powder of making of porphyrize and be added in cotton, silk, fiber crops, third, the bright and beautiful viscose rayon spinning liquid, the ratio of proportioning 4～10% is made the fabric belt, as does not have the condition can be by the traditional method method for making.
2. it is standby said medicine to be pulverized 100 mesh sieves, and get said medicine 150g with the cotton of good permeability and make and be about 300mm, the oval medicated bag of wide about 220mm, the little groined type of middle reuse is made several times, in case medicated powder is walked to scurry up and down.Outer herringbone leather with same form is sewed together with medicated core, and internal layer is made the liner sheath that can change clothes with cotton and got final product, and can do an activity or fixing band as required, in order to fixing waistline.
3. get Semen Sinapis Albae, Herba Asari, Olibanum, Myrrha, each 50g of Cortex Cinnamomi, respectively account for 8.6%; Radix Angelicae Pubescentis, Radix Angelicae Sinensis, each 100g of Rhizoma Atractylodis respectively account for 17.2%; Borneolum Syntheticum 30g accounts for 5.2%, will add medicine to and pulverize 800 mesh sieves, gets 95% ethanol 10000ml again, makes concentrated synergy liquid with osmosis, gets medicine-feeding 50ml simultaneously and adds Chinese liquor and each 100ml of mature vinegar, fully is the regeneration synergy liquid behind the mixing.
(3) using method:
The Chinese medicine waistline is placed lumbosacral region, fix with waist-belt or movable fixedly band, 4～5h is with in beginning every day, and along with the going down of drug effect, the time of wearing also prolongs thereupon later on, and can be with 10h maximum every days.After using 15～20d, if flavour of a drug are not obvious or about when weakening, get the regeneration synergy liquid and pack in the little plastics watering can,, medicinal liquid evenly is sprayed at the medicated core surface by spray ten remainders, after treating that medicinal liquid is exhausted by medicated powder in the medicated core, continue to wear, its drug effect does not subtract, later on every 4～5d spray once, 5～7d carried out for second course of treatment at interval, can select 3～4 courses of treatment according to the state of an illness.
(4) criterion of therapeutical effect:
Cure: pain, the symptom of aching complete obiteration, functional activity recover normal;
Produce effects: pain, the symptom of aching disappear substantially, and it is normal that functional activity recovers substantially;
Take a turn for the better: pain, the sx of aching, functional activity makes moderate progress;
Invalid: pain and dysfunction no change before and after the treatment.
(5) therapeutic outcome is compared:
1. general clinical data: in totally 150 examples, male 82 examples, women 68 examples, the oldest 75 years old, minimum 32 years old, the longest 27a of the course of disease, the shortest 0.5a.Clinical diagnosis: prolapse of lumbar intervertebral disc 48 examples, lumbar spinal stenosis 18 examples, lumbar muscle strain 51 examples, lumbar fascia damages 11 examples, degeneration spondylitis 7 examples, third lumbar vertebra transverse process syndrome 5 examples, joint of lumbar vertebra bursitis 4 examples.
2. therapeutic outcome:
Two kinds of Therapeutic Method curative effects relatively
| Group is totally 150 examples | Recovery from illness | Produce effects | Effectively | Invalid | Effective percentage |
| The directly drug of topical application | 48(32％) | 72(48％) | 22(14.7％) | 8(5.3％) | 94.7％ |
| The fabric belt | 71(47.3％) | 75(50％) | 3(2％) | 1(0.7％) | 99.3％ |
(6) model case:
Yao * *, man, 53 years old, the teacher suffered from prolapse of lumbar intervertebral disc before 2 days, and methods such as channel, massage, cup are cured, recurrence after 12 days often feels that the waist buttocks aches, and radiates the tired postemphasis of particularly sitting to right lower extremity, after using the Chinese medicine waistline instead and wearing treatment 2h, conscious pair of lower limb are damp and hot, and the right lower extremity pain also begins to alleviate thereupon, after wearing 10 days, the symptom complete obiteration was worn later on to 3 courses of treatment always, and all symptoms disappear entirely and heal.
(7) discuss:
Chronic lambago and skelalgia can be caused that comparatively common and multiple with middle-aged and elderly people, the traditional Chinese medical science belongs to " muscle and tendon injury ", " arthralgia aggravated by cold " category by multiple disease.Because the hypofunction of middle-aged and elderly people internal organs, meridian function is low, deficiency of the liver and kindey, and deficiency of qi and blood adds to toil away excessively, decreases its muscle muscle arteries and veins, causes venation resistance numbness, stagnation of QI-blood, general rule is illogical.At the cause of disease of middle-aged and elderly people chronic lambago and skelalgia, and most of patients is liked the characteristics that hot aversion to cold gets warm alleviation of pain, the medicine of Chinese medicine waistline prescription multiselect dispelling cold by warming the meridian, blood circulation promoting and blood stasis dispelling, expelling wind and removing dampness, liver and kidney tonifying, carry out treating both the principal and secondary aspects of a disease, make passages through which vital energy circulates unimpeded, muscles and bones is strong, reaches not bitterly purpose of general rule.Have the far infrared radiation material in the medicine, can go deep into subcutaneous 3～5mm heating that heats up automatically,, quicken the unimpeded obstruction of blood flow so can urge dead microcirculation.Reach the purpose of rapid healing.
Chinese medicine fabric waistline external treatment with Chinese medicine category has to be worn comfortablely, easy to use, economical and practical, evident in efficacy, from being ready to like one by one treating no pain, only is to wear a belt, does not have any misery and untoward reaction, the characteristics that are easy to adhere to.Observe the use effective percentage through clinical 150 examples and reach 99%, do not see any toxic and side effects, be that the healthy fabric external treatment of treatment chronic lambago and skelalgia traditional Chinese medical science spinning preferably belt is the extension of ancient traditional Chinese medical science hat and clothes therapy, it is the nano ceramics fine powder of making through modern nanotechnology by effective tcm prescription, proportioning by 4%～15% is added on the functional fabric of making in cotton, silk, fiber crops, third, the acrylic spinning liquid, be used for prevention and treatment disease, new medication precedent is provided.
5, Chinese medicine preparation 5: the heel pain socks
Rhizoma Chuanxiong, each 50g of Herba Asari respectively account for 34.5%; Cortex Cinnamomi 15g accounts for 10.3%; Borneolum Syntheticum 30g accounts for 20.7%.
Usage: the medicine-feeding grind into powder or nanotechnology after be added in the fiber spinning solution, the beanbag of making heel shape is in socks.
6, Chinese medicine preparation 6: the chest stuffiness relieving band is controlled rib power chondritis
1. rhizoma sparganic, Rhizoma Curcumae, Olibanum, each 150g of Myrrha respectively account for 15.6%; Radix Et Rhizoma Rhei, each 180g of the Radix Angelicae Dahuricae respectively account for 18.8%;
2. Rhizoma Et Radix Notopterygii, Radix Clematidis, Zaocys, each 150g of Radix Salviae Miltiorrhizae respectively account for 9.1%; SHENJINGU, each 100g of the Radix Angelicae Dahuricae respectively account for 6.1%; Caulis Lonicerae, each 250g of Caulis Piperis Kadsurae respectively account for 15.2%; Rhizoma Chuanxiong, Olibanum, Radix Aconiti Kusnezoffii, each 75g of Radix Aconiti respectively account for 4.5%; Radix Puerariae 300g accounts for 18.2%.
Embodiment two; Maifanitum, tourmaline Chinese medicinal formulae proportioning %
1. a certain effect prescription 55% of Chinese medicine
2. Maifanitum nano powder Al
2O
3, Fe
2O
3, SiO
2, ZnO 20%
3. tourmaline nano powder FeO, TiO
2, SiO
2, MgO 20%
4. silver-carrying nano (AT) titanium dioxide anti-bacterial agent 5%
Embodiment three: the nano-negative ion far infrared
900 fabric proportioning %
1. Maifanitum, tourmaline Chinese medicinal formulae proportioning 8%
2. nano-far-infrared anion powder
900 2%
3. in cotton, fiber crops, Pilus Caprae seu Ovis, brocade, third, the polyster fibre spinning liquid 90%
Embodiment four: the anion far infrared
700 fabric proportioning %
1. Maifanitum, tourmaline Chinese medicinal formulae proportioning 8%
2. anion far infrared health size
700 2%
3. in cotton, fiber crops, Pilus Caprae seu Ovis, silk, nitrile, brocade, third, the viscose rayon spinning liquid 90%
Embodiment five: anion far-infrared finishing agent fabric proportioning %
1. Maifanitum, tourmaline Chinese medicinal formulae proportioning 8%
2. anion far-infrared finishing agent
888 2%
3. in cotton, fiber crops, silk, nitrile, brocade, third, the polyster fibre spinning liquid 90%.
Claims (5)
1. nano-magnetic anion far infrared effect hat and clothes therapy articles for use is characterized in that: be made up of following proportioning
(1) Chinese medicine preparation 1
Hirudo, Fructus Evodiae, each 20～80g of Radix Platycodonis respectively account for 1～10%; Ramulus Uncariae Cum Uncis, each 70～180g of Semen Cassiae respectively account for 6～16%; Rhizoma Chuanxiong, Flos Chrysanthemi, Folium Mori, Spica Prunellae, each 50～150g of Semen Sinapis Albae respectively account for 4～16%; Rhizoma Gastrodiae 30～130g accounts for 2～13%; Borneolum Syntheticum 20～40g accounts for 1～4%; Cortex Cinnamomi 10～30g accounts for 1～3%.
(2) Chinese medicine preparation 2: dysmenorrhea is loose or bag is controlled dysmenorrhea
Cortex Cinnamomi, Rhizoma Zingiberis Preparatum, Oletum Trogopterori, Pollen Tyjphae, each 30～90g of Rhizoma Corydalis respectively account for 5～15%; Radix Angelicae Sinensis, Rhizoma Chuanxiong, Radix Paeoniae Rubra, Semen Persicae, each 20～80g of Rhizoma Cyperi respectively account for 3～13%; Succinum end 10～20g accounts for 1～4%;
Or, respectively accounting for 20～30% with Cortex Cinnamomi, Rhizoma Corydalis, Herba Asari, each 20～80g of Fructus Foeniculi, deposited umbilicus is controlled and is stimulated the menstrual flow.
(3) Chinese medicine preparation 3: applying Chinese medicine to the umbilicus bag treatment intractable cirrhotic ascites
Radix Phytolaccae 50～150g accounts for 50～80%; Moschus 1～5g accounts for 0.5～3%; Resina Ferulae, each 20～40g of Borax respectively account for 13～23%, grind the deck of packing into into powder, apply umbilicus treating the liver sclerosis ascites.
(4) Chinese medicine preparation 4: the Chinese medicine waistline is controlled chronic lambago and skelalgia
Radix Aconiti, Radix Aconiti Kusnezoffii, Semen Strychni (processed), Semen Sinapis Albae, Herba Asari, Olibanum, Myrrha, Cortex Cinnamomi, each 20～80g of Borneolum Syntheticum respectively account for 0.5～3%; Canis familiaris L. spring, Rhizoma Drynariae, the Cortex Eucommiae, each 80～120g of Radix Angelicae Sinensis respectively account for 1～4%; Scholar unit, Radix Cyathulae, Radix Clematidis, Radix Angelicae Pubescentis, Periostracum Cicadae, Radix Gentianae Macrophyllae, Rhizoma Atractylodis, Cortex Phellodendri, Rhizoma Polygonati Odorati, each 150～250g of the Radix Paeoniae Alba respectively account for 1～10%; Radix Salviae Miltiorrhizae, Semen Coicis, each 250～350g of Magnetitum respectively account for 3～13%.
(5) Chinese medicine preparation 5: the heel pain socks
Rhizoma Chuanxiong, each 30～70g of Herba Asari respectively account for 29～40%; Cortex Cinnamomi 10～20g accounts for 5～15%; Borneolum Syntheticum 20～40g accounts for 15～25%.
(6) Chinese medicine preparation 6: the chest stuffiness relieving band is controlled rib power chondritis
1. rhizoma sparganic, Rhizoma Curcumae, Olibanum, each 100～200g of Myrrha respectively account for 10～20%; Radix Et Rhizoma Rhei, each 130～230g of the Radix Angelicae Dahuricae respectively account for 13～24%;
2. Rhizoma Et Radix Notopterygii, Radix Clematidis, Zaocys, each 100～200g of Radix Salviae Miltiorrhizae respectively account for 4～14%; SHENJINGU, each 50～150g of the Radix Angelicae Dahuricae respectively account for 1～11%; Caulis Lonicerae, each 200～300g of Caulis Piperis Kadsurae respectively account for 10～20%; Rhizoma Chuanxiong, Olibanum, Radix Aconiti Kusnezoffii, each 50～100g of Radix Aconiti respectively account for 1～9%; Radix Puerariae 250～350g accounts for 13～24%.
2. according to claim 1, nano-magnetic anion far infrared effect hat and clothes therapy articles for use is characterized in that: Maifanitum, tourmaline Chinese medicinal formulae proportioning %
1. a certain effect prescription 50～60% of Chinese medicine
2. Maifanitum nano powder Al
2O
3, Fe
2O
3, SiO
2, ZnO 15～25%
3. tourmaline nano powder FeO, TiO
2, SiO
2, MgO 15～25%
4. silver-carrying nano (AT) titanium dioxide anti-bacterial agent 1～9%
3. according to claim 2, nano-magnetic anion far infrared effect hat and clothes therapy articles for use is characterized in that: the nano-negative ion far infrared
900 fabric proportioning %
1. Maifanitum, tourmaline Chinese medicinal formulae proportioning 5～13%
2. nano-far-infrared anion powder
900 1～3%
3. in cotton, fiber crops, Pilus Caprae seu Ovis, brocade, third, the polyster fibre spinning liquid 85～95%
4. according to claim 3, nano-magnetic anion far infrared effect hat and clothes therapy articles for use is characterized in that: the anion far infrared
700 fabric proportioning %
1. Maifanitum, tourmaline Chinese medicinal formulae proportioning 5～13%
2. anion far infrared health size
700 1～3%
3. in cotton, fiber crops, Pilus Caprae seu Ovis, silk, nitrile, brocade, third, the viscose rayon spinning liquid 85～95%
5. according to claim 4, nano-magnetic anion far infrared effect hat and clothes therapy articles for use is characterized in that: anion far-infrared finishing agent fabric proportioning %
1. Maifanitum, tourmaline Chinese medicinal formulae proportioning 5～13%
2. anion far-infrared finishing agent
888 1～3%
3. in cotton, fiber crops, silk, nitrile, brocade, third, the polyster fibre spinning liquid 85～95%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010102760646A CN102091237A (en) | 2010-09-08 | 2010-09-08 | Product for nano magnetic-anion far-infrared functional dress therapy |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010102760646A CN102091237A (en) | 2010-09-08 | 2010-09-08 | Product for nano magnetic-anion far-infrared functional dress therapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102091237A true CN102091237A (en) | 2011-06-15 |
Family
ID=44124617
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010102760646A Pending CN102091237A (en) | 2010-09-08 | 2010-09-08 | Product for nano magnetic-anion far-infrared functional dress therapy |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102091237A (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102920033A (en) * | 2012-11-08 | 2013-02-13 | 浙江东方百富袜业制造有限公司 | Thermal and healthy sock with multilayer structure |
| WO2013075391A1 (en) * | 2011-11-22 | 2013-05-30 | 山东超瑞施医疗科技有限公司 | Electromagnetic therapeutic apparatus and supporting physiotherapy liquid thereof |
| CN104499071A (en) * | 2014-12-22 | 2015-04-08 | 青岛大统纺织开发有限公司 | Traditional Chinese medicine anthelmintic auxiliary agent and application thereof |
| CN104695034A (en) * | 2015-01-15 | 2015-06-10 | 青岛恒波仪器有限公司 | Traditional Chinese medicine mosquito expelling composition and application thereof |
| CN105884003A (en) * | 2016-04-08 | 2016-08-24 | 贵州玉米科技有限公司 | Energy enhancing device for liquid |
| CN108030195A (en) * | 2017-12-16 | 2018-05-15 | 李竑靓 | A kind of preparation method of antibacterial insoles |
| CN108577029A (en) * | 2018-04-23 | 2018-09-28 | 陈汉良 | Traditional Chinese medicine negative ion insole nanometer additive and traditional Chinese medicine negative ion insole |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101961156A (en) * | 2010-06-02 | 2011-02-02 | 成钢 | Nano AgFe2O3 antibacterial deodorization far infrared magnetic health-care shoe |
| CN101978910A (en) * | 2009-10-23 | 2011-02-23 | 成钢 | Snake bee nano-selenium element Chinese medicinal anion far infrared multi-functional navel-warming bag shorts |
-
2010
- 2010-09-08 CN CN2010102760646A patent/CN102091237A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101978910A (en) * | 2009-10-23 | 2011-02-23 | 成钢 | Snake bee nano-selenium element Chinese medicinal anion far infrared multi-functional navel-warming bag shorts |
| CN101961156A (en) * | 2010-06-02 | 2011-02-02 | 成钢 | Nano AgFe2O3 antibacterial deodorization far infrared magnetic health-care shoe |
Non-Patent Citations (9)
| Title |
|---|
| 《中医外治杂志》 19951231 马静昆 自拟痛经散敷脐治疗痛经40例 40 1-5 , 第5期 * |
| 《中医外治杂志》 19951231 马静昆 自拟痛经散敷脐治疗痛经40例 40 1-5 , 第5期 2 * |
| 《中医外治杂志》 19961231 石长秀等 中药垫治疗更痛证30例 46 1-5 , 第3期 * |
| 《中医外治杂志》 20010228 裴鸿文等 降压药垫治疗高血压病300 例 6-7 1-5 第10卷, 第1期 * |
| 《中医外治杂志》 20010228 裴鸿文等 降压药垫治疗高血压病300 例 6-7 1-5 第10卷, 第1期 2 * |
| 《中医外治杂志》 20050630 夏德君 中药腰围治疗慢性腰腿痛120例 15 1-5 第14卷, 第3期 * |
| 《中医外治杂志》 20050630 夏德君 中药腰围治疗慢性腰腿痛120例 15 1-5 第14卷, 第3期 2 * |
| 《实用中西医结合杂志》 19971231 单劲干 加味萆 分清饮治疗慢性前列腺炎34 例 2190 1-5 第10卷, 第22期 * |
| 《实用中西医结合杂志》 19971231 单劲干 加味萆分清饮治疗慢性前列腺炎34 例 2190 1-5 第10卷, 第22期 2 * |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013075391A1 (en) * | 2011-11-22 | 2013-05-30 | 山东超瑞施医疗科技有限公司 | Electromagnetic therapeutic apparatus and supporting physiotherapy liquid thereof |
| CN102920033A (en) * | 2012-11-08 | 2013-02-13 | 浙江东方百富袜业制造有限公司 | Thermal and healthy sock with multilayer structure |
| CN104499071A (en) * | 2014-12-22 | 2015-04-08 | 青岛大统纺织开发有限公司 | Traditional Chinese medicine anthelmintic auxiliary agent and application thereof |
| CN104695034A (en) * | 2015-01-15 | 2015-06-10 | 青岛恒波仪器有限公司 | Traditional Chinese medicine mosquito expelling composition and application thereof |
| CN105884003A (en) * | 2016-04-08 | 2016-08-24 | 贵州玉米科技有限公司 | Energy enhancing device for liquid |
| CN108030195A (en) * | 2017-12-16 | 2018-05-15 | 李竑靓 | A kind of preparation method of antibacterial insoles |
| CN108577029A (en) * | 2018-04-23 | 2018-09-28 | 陈汉良 | Traditional Chinese medicine negative ion insole nanometer additive and traditional Chinese medicine negative ion insole |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102091237A (en) | Product for nano magnetic-anion far-infrared functional dress therapy | |
| CN101524513B (en) | Health pillow drug core | |
| CN106309972A (en) | Traditional Chinese medicine composition for prevention and external treatment of diabetes and use method | |
| CN103893545A (en) | Moxa stick for improving brain health and preparation method of moxa stick | |
| CN103393591A (en) | Deodorant enzyme body wash | |
| CN101590004B (en) | Chinese medicament bath foam | |
| CN111035748A (en) | Traditional Chinese medicine composition for improving myopia, external application preparation for improving myopia and eye patch for improving myopia | |
| CN102178357A (en) | Chinese medicinal health-care bra for treating hyperplasia of mammary glands and preparation method thereof | |
| KR20120133048A (en) | Funcktional clothes with anti-cellulite capsule | |
| CN103656549A (en) | Foot fumigation prescription for treating dysmenorrhea due to yang deficiency and predominant cold | |
| CN102716334B (en) | Chinese medicinal composition for dispelling the cold and removing stasis | |
| CN102908474B (en) | Medicinal liquor for treating neurosis | |
| CN101810824B (en) | Traditional Chinese medicine for treating post-stroke shoulder-hand syndrome by fumigation and external washing | |
| CN107375744A (en) | A kind of bathing powder and its application method | |
| CN102068634B (en) | Externally applied ironing moxibustion clay for human body and manufacturing method thereof | |
| CN109674704A (en) | A kind of Chinese medicine bathing antibacterial liquid/particle improving damp-heat constitution and preparation and application method | |
| CN107744563A (en) | A kind of physical fitness health care bath powder | |
| CN103007214A (en) | Chinese medicinal composition for treating palpitation | |
| CN104257917B (en) | A kind of precious jade medicine external preparation for preventing and treating woman puerperal fever and preparation method thereof | |
| CN102772744A (en) | External traditional Chinese medicine preparation for excreting body toxin | |
| CN102526541B (en) | Composition for effectively conditioning female climacteric syndrome | |
| CN110339323A (en) | A kind of Chinese medicine composition and its preparation method and application for treating bradycardia | |
| CN104208412A (en) | Traditional Chinese medicine preparation with functions of nourishing and blackening hair and promoting hair growth | |
| CN101181483B (en) | Chinese patent drug for curing cataptosis and hemiparalysis sequela | |
| CN102961540A (en) | Medicine for treating coronary heart disease and preparation method for same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20110615 |